WallStreetZenWallStreetZen

NASDAQ: IDXX
Idexx Laboratories Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Idexx Laboratories earnings were $887.9M for the trailing 12 months ending Dec 31, 2024, with 5.9% growth year over year. The latest IDXX earnings report on Dec 31, 2024 announced Q4 2024 earnings of $216.1M, down 7.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IDXX reported annual earnings of $887.9M, with 5.1% growth.

IDXX past earnings growth

How has IDXX's earnings growth performed historically?

Company
5.9%
Industry
0%
Market
64.34%
IDXX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
IDXX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
IDXX's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

IDXX earnings history

Current Revenue
$3.9B
Current Earnings
$887.9M
Current Profit Margin
22.8%
IDXX's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

IDXX Return on Equity

Current Company
55.8%
Current Industry
-10.9%
Current Market
34.1%
IDXX's Return on Equity (55.8%)... subscribe to Premium to read more.
High Return on Equity Performance

IDXX undefined

Current Company
26.5%
Current Industry
5.7%
IDXX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IDXX announces earnings.

IDXX undefined

Current Company
51.27%
Current Industry
9.7%
IDXX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IDXX vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IDXX$1.27B$887.87M+16.73%$10.77
A$1.85B$1.26B+12.27%$4.37
IQV$3.46B$1.37B+50.51%$7.57
MTD$1.24B$863.14M+12.23%$40.67
NTRA-$132.75M-$190.43MN/A-$1.53
View Top Diagnostic & Research Stocks

Idexx Laboratories Earnings Reports & History FAQ

What were Idexx Laboratories's earnings last quarter?

On IDXX's earnings call on Invalid Date, Idexx Laboratories (NASDAQ: IDXX) reported Q4 2024 earnings per share (EPS) of $2.65, up 13.25% year over year. Total IDXX earnings for the quarter were $216.15 million. In the same quarter last year, Idexx Laboratories's earnings per share (EPS) was $2.34.

If you're new to stock investing, here's how to buy Idexx Laboratories stock.

Is Idexx Laboratories profitable or losing money?

As of the last Idexx Laboratories earnings report, Idexx Laboratories is currently profitable. Idexx Laboratories's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $887.87 million, a 5.07% increase year over year.

What was IDXX's earnings growth in the past year?

As of Idexx Laboratories's earnings date in Invalid Date, Idexx Laboratories's earnings has grown 5.9% year over year. This is 5.9 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 0%. IDXX earnings in the past year totalled $887.87 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.